Delivery Order SPE2DB25D3012-SPE2DB25FWZZU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,982.71 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,522.97 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, awarded on July 25, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $29,726.93 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $7,642.01 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gemtesa 75 mg tablets (90-count package) with completion targeted for September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a contract ceiling value of $27,331.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order has an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $21,516.85 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Gemtesa 75 mg tablets (90-count packages). The contract, which is not set-aside and utilizes firm fixed pricing, will be completed by September 11, 2025, with performance conducted at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,350.51 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gemtesa 75 mg tablets (90-count). This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. The contract utilizes no set-aside designation, reflecting the vendor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $39,246.38 delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) with a firm fixed price structure and an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract was issued on August 1, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,864.48 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order fulfilling federal pharmaceutical procurement needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZZUDelivery Order
The Defense Logistics Agency (DLA) awarded a $52,877.64 delivery order to AmerisourceBergen Drug Corp for supply of Gemtesa 75 mg tablets (90-count units) with a completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was competitively awarded on September 12, 2025, as part of AmerisourceBergen's broader federal medical supply portfolio supporting military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen demonstrates extensive capability in fulfilling diverse pharmaceutical requirements through open competition, with this contract supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.9k | 9/12/25 |